文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.

作者信息

Broadhead Geoffrey K, Chang Andrew

机构信息

Sydney Retina Clinic & Day Surgery, Sydney, Australia.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):979-81. doi: 10.1007/s00417-014-2891-0. Epub 2014 Dec 31.

DOI:10.1007/s00417-014-2891-0
PMID:25547617
Abstract
摘要

相似文献

[1]
Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.

Graefes Arch Clin Exp Ophthalmol. 2015-6

[2]
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.

Br J Ophthalmol. 2020-7

[3]
Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study.

Eye (Lond). 2019-11

[4]
Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.

Br J Ophthalmol. 2015-8

[5]
ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.

Retina. 2016-5

[6]
Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.

Eye (Lond). 2016-6

[7]
One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.

Ophthalmology. 2015-6-16

[8]
Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy.

JAMA Ophthalmol. 2015-10

[9]
Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.

Eye (Lond). 2016-4

[10]
INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.

Retina. 2016-4

引用本文的文献

[1]
Clinical efficacy of intravitreal corticoid as an adjunctive therapy to anti-VEGF treatment of neovascular age-related macular degeneration: a Meta-analysis.

Int J Ophthalmol. 2021-7-18

[2]
Risk Factors and Outcomes of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy.

Sci Rep. 2019-3-8

本文引用的文献

[1]
Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.

Ophthalmology. 2013-10-18

[2]
Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration.

Retina. 2013-9

[3]
Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy.

Eur J Ophthalmol. 2012

[4]
Factors influencing the visual acuity of chronic central serous chorioretinopathy.

Korean J Ophthalmol. 2011-4

[5]
Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.

Eur J Ophthalmol. 2010

[6]
Central serous chorioretinopathy: a personal perspective.

Am J Ophthalmol. 2010-3

[7]
Cystoid macular degeneration in chronic central serous chorioretinopathy.

Retina. 2003-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索